Dr. Gauthier is a world-renowned researcher whose contributions include design and implementation of randomized clinical trials to establish the safety and efficacy of cholinesterase inhibitors, muscarinic agonists, and agents possibly modifying progression of Alzheimer’s disease and vascular dementia.

He was a recipient of the Prix Galien Award in 1997 and has authored over 700 peer-reviewed articles. He was appointed to the Order of Canada in 2014 and the Ordre National du Québec in 2017 for his contributions to advancing our understanding ofAlzheimer’s disease and dementia.